| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 3.14 | 0.00 (0.00%) | 2.33 - 4.60 | 361.1 thousand (Above Avg) |
Market data as of 4:00PM 06/17/13. Quotes are delayed by at least 15 min.
| Open | 3.20 |
|---|---|
| Previous Close | 3.14 |
| Day's Range | 3.08 - 3.28 |
| Market Cap | 163.7M |
| Avg Volume (10 Day) | 237.5K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.29 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Delaware Supreme Court Affirms Lower Court's Ruling That SIGA Technologies Breached Its Contractual Obligation To Negotiate In Good Faith
PR Newswire - Sunday 05/26/2013 10:00 AM ET
| SIGA | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -29.30% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.19 | |
| LT Debt/Equity | 0.14 | |
| Earnings Yield | -- | |
| Price/Sales | 18.59 |
| Company | Last | Change |
|---|---|---|
| Alimera Sciences Inc | 5.40 | +6.93% |
| Rockwell Medical Inc | 4.05 | +2.79% |
| Horizon Pharma Inc | 2.25 | 0.00% |
| Zogenix Inc | 1.47 | +5.00% |
| KaloBios Pharmaceuticals Inc | 4.98 | -0.80% |
Data is delayed by at least 15 min.